Retrieve available abstracts of 8 articles: HTML format
Single Articles
August 2025
KAUSAR MA, Alshammari KF, Alenazi F, Anwar S, et al RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated
breast and ovarian cancers (Review).
Int J Oncol. 2025;67:65. PubMedAbstract available
LIU R, Martin TA, Jordan NJ, Ruge F, et al [Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The
impact on cellular migration and metastasis.
Int J Oncol. 2025;67:64. PubMedAbstract available
December 2024
LIU Y, Xiao H, Zeng H, Xiang Y, et al Beyond tumor?associated macrophages involved in spheroid formation and
dissemination: Novel insights for ovarian cancer therapy (Review).
Int J Oncol. 2024;65:117. PubMedAbstract available
November 2024
ZHU Y, Yang W, Wang X, Chen M, et al AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote
the malignant progression of cervical cancer.
Int J Oncol. 2024;65:107. PubMedAbstract available
TAN H, He Q, Gong G, Wang Y, et al [Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through
regulating EMT in ovarian cancer.
Int J Oncol. 2024;65:110. PubMedAbstract available
October 2024
SUN J, Chu H, Ji J, Huo G, et al [Retracted] Long non?coding RNA HOTAIR modulates HLA?G expression by absorbing
miR?148a in human cervical cancer.
Int J Oncol. 2024;65:97. PubMedAbstract available
August 2024
XU S, Zhu C, Xu Q, An Z, et al ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo
pathway.
Int J Oncol. 2024;65:76. PubMedAbstract available
June 2024
FU M, Deng F, Chen J, Fu L, et al Current data and future perspectives on DNA methylation in ovarian cancer
(Review).
Int J Oncol. 2024;64:62. PubMedAbstract available